15373740 · Active · incorporated 2 years, 7 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Seed
OligoTune develops advanced RNA-powered tools to enhance anti-tumour immunity, focusing on reprogramming the tumour microenvironment to overcome checkpoint therapy resistance.
See the complete cap table with every shareholder, founder tags, dilution across 2 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.